Andy King
Head of Trials Programming
After graduating from the University of Oxford with a BA in Mathematics, Andy was self-employed as a computer programmer working for several Oxford colleges and the NHS.
Since joining the NPEU in 1996 he has worked on numerous projects (including 4Child and UKCP) and clinical trials (including the Hip Trial, INIS, BOOST-II UK, I2S2, PiPS, Poppi and Baby-OSCAR). In 2009 he became Senior Trials Programmer, and in 2014 was appointed Head of Trials Programming. He is responsible for the IT management of the NPEU CTU's work, including the computing aspects of the design and conduct of NPEU CTU randomised controlled trials, and has particular responsibility for the randomisation systems.
Recent publications
-
Techniques to increase lumbar puncture success in newborn babies: the NeoCLEAR RCT.
Journal article
Roehr CC. et al, (2023), Health Technol Assess, 27, 1 - 97
-
2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheterisation: the ARCTIC randomised controlled feasibility trial.
Journal article
Clarke P. et al, (2023), Arch Dis Child Fetal Neonatal Ed
-
Mixed-methods feasibility study to inform a randomised controlled trial of proton pump inhibitors to reduce strictures following neonatal surgery for oesophageal atresia.
Journal article
Mitchell TK. et al, (2023), BMJ Open, 13
-
Frenotomy with breastfeeding support versus breastfeeding support alone for infants with tongue-tie and breastfeeding difficulties: the FROSTTIE RCT
Journal article
Knight M. et al, (2023), Health Technology Assessment, 27
-
Transfer of thawed frozen embryo versus fresh embryo to improve the healthy baby rate in women undergoing IVF: the E-Freeze RCT.
Journal article
Maheshwari A. et al, (2022), Health Technol Assess, 26, 1 - 142